CNS Pharmaceuticals Inc. (CNSP)

2.20

-0.23 (-9.47%)

At close: Mar 03, 2025, 3:59 PM

2.24

1.77%

After-hours: Mar 03, 2025, 04:59 PM EST

CNS Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-18.85M	-15.27M	-14.04M	-9.46M	-3.88M	-7.39M	-219.36K
Depreciation & Amortization	4.13K	11.76K	13.07K	11.1K	1.96K	n/a	n/a
Stock-Based Compensation	1.01M	1.2M	1.72M	1.29M	477.1K	110.24K	119.85K
Other Working Capital	2.38M	1.46M	-1.82M	176.95K	-579.23K	12.41K	-10.25K
Other Non-Cash Items	498.00	337.25K	714.87K	1.58K	270.31K	6.48M	2.42K
Deferred Income Tax	n/a	n/a	-714.87K	n/a	n/a	n/a	n/a
Change in Working Capital	3.7M	3.16M	-1.24M	833.78K	-425.62K	83.78K	47.25K
Operating Cash Flow	-14.14M	-10.56M	-13.54M	-7.32M	-3.55M	-716.38K	-112.2K
Capital Expenditures	-3.9K	-4.42K	-5.75K	-17.95K	-20.12K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-3.9K	-4.42K	-5.75K	-17.95K	-20.12K	n/a	n/a
Debt Repayment	-438.73K	n/a	n/a	-43.08K	-35K	300K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.76M	15.61M	4.51M	-45K	n/a	860.98K	222.74K
Financial Cash Flow	4.64M	15.61M	4.51M	14.13M	10.26M	1.16M	222.74K
Net Cash Flow	-9.51M	5.05M	-9.03M	6.8M	6.69M	444.59K	110.54K
Free Cash Flow	-14.14M	-10.56M	-13.54M	-7.34M	-3.57M	-716.38K	-112.2K